The combination of accelerating top-line growth, expanding margins, strong guidance, and increased capital returns suggests robust operational execution. Traders should monitor whether the stock re-rates on improved profitability expectations and whether Q1 2026 results meet the high end of guidance ($67.6 million revenue).
Price Chart
Executive Summary
LeMaitre Vascular (LMAT) reported strong Q4 2025 results with revenue of $64.5 million (+16% YoY) and diluted EPS of $0.68 (+39% YoY), driven by international growth and margin expansion. The company raised its quarterly dividend by 25% to $0.25/share and authorized a $100 million share repurchase program. Full-year 2026 guidance calls for $280 million in sales (+12%) and operating income of $77.8 million (+21% adjusted), signaling continued profitability growth.
Key Financial Metrics
Key Facts
- Q4 2025 revenue: $64.5 million (+16% YoY, +15% organic)
- Q4 2025 diluted EPS: $0.68 (+39% YoY)
- Gross margin expanded 240 bps to 71.7%
- Operating income: $18.8 million (+47% YoY)
- 2026 full-year sales guidance: $276–284 million (midpoint $280 million, +12%)
- 2026 full-year operating income guidance: $75.0–80.7 million (midpoint $77.8 million, +15% GAAP, +21% adjusted)
- Quarterly dividend increased 25% to $0.25/share
- Authorized $100 million share repurchase program
Financial Impact
Revenue up $8.7 million YoY, operating income up $5.9 million YoY, with $100 million in capital returned via buyback authorization
Segment Breakdown
| Segment | Growth |
|---|---|
| Grafts | +27.0% |
| Valvulotomes | +20.0% |
| Carotid Shunts | +18.0% |
Risk Factors
- Forward-looking guidance is subject to risks including international market volatility and supply chain disruptions
- Increased share count from convertible notes could dilute EPS if not offset by buybacks
- Valuation could become stretched if execution falters
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-071954 |
| Document: d23187d8k.htm | 0001193125-26-071954 |
| Document: 0001193125-26-071954-index-headers.html | 0001193125-26-071954 |
| Document: 0001193125-26-071954-index.html | 0001193125-26-071954 |
| Document: 0001193125-26-071954.txt | 0001193125-26-071954 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | Press Release | $80.45 $82.34 | ▲ +2.35% | ▲ +2.09% | $78.78 (−2.08%) |
Jul 14, 2026 11w ago | Press Release | $99.79 $82.13 | ▲ +17.70% | ▲ +20.04% | $78.78 (+21.06%) |
May 7, 2026 21w ago | Insider Cluster | $107.91 $91.64 | ▲ +15.08% | ▲ +18.21% | $78.78 (+27.00%) |
May 7, 2026 21w ago | Insider Cluster | $107.91 $91.64 | ▼ −15.08% | ▼ −18.21% | $78.78 (−27.00%) |
May 7, 2026 21w ago | Insider Cluster | $107.91 $91.64 | ▼ −15.08% | ▼ −18.21% | $78.78 (−27.00%) |
May 5, 2026 21w ago | 8-K | $110.22 $91.64 | ▼ −16.86% | ▼ −19.64% | $78.78 (−28.53%) |
Apr 14, 2026 24w ago | DEFA14A | $117.39 $101.64 | ▼ −13.42% | ▼ −19.71% | $78.78 (−32.89%) |
Apr 14, 2026 24w ago | 8-K | $117.39 $101.64 | ▼ −13.42% | ▼ −19.71% | $78.78 (−32.89%) |
Mar 11, 2026 29w ago | Insider Cluster | $108.09 $112.71 | ▲ +4.27% | ▲ +3.75% | $78.78 (−27.12%) |
Feb 26, 2026 31w ago | Insider Cluster | $113.43 $110.33 | ▲ +2.73% | ▼ −3.67% | $78.78 (+30.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access